Academic Journals Database
Disseminating quality controlled scientific knowledge

Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation

ADD TO MY LIST
 
Author(s): Amy H. Moore | Matthew J. Bigbee | Grace E. Boynton | Colin M. Wakeham | Hilary M. Rosenheim | Christopher J. Staral | James L. Morrissey | Amanda K. Hund

Journal: Pharmaceuticals
ISSN 1424-8247

Volume: 3;
Issue: 6;
Start page: 1812;
Date: 2010;
Original page

Keywords: Non-steroidal anti-inflammatory drugs | Alzheimer's disease | Parkinson's disease | cyclooxygenase | neuroinflammation

ABSTRACT
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases with age as the greatest risk factor. As the general population experiences extended life span, preparation for the prevention and treatment of these and other age-associated neurological diseases are warranted. Since epidemiological studies suggested that non-steroidal anti-inflammatory drug (NSAID) use decreased risk for AD and PD, increasing attention has been devoted to understanding the costs and benefits of the innate neuroinflammatory response to functional recovery following pathology onset. This review will provide a general overview on the role of neuroinflammation in these neurodegenerative diseases and an update on NSAID treatment in recent experimental animal models, epidemiological analyses, and clinical trials.
Why do you need a reservation system?      Save time & money - Smart Internet Solutions